Search hospitals > Kansas > Lawrence
Lawrence Memorial Hospital
Claim this profileLawrence, Kansas 66044
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
395 reported clinical trials
23 medical researchers
Summary
Lawrence Memorial Hospital is a medical facility located in Lawrence, Kansas. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Lawrence Memorial Hospital is involved with conducting 395 clinical trials across 489 conditions. There are 23 research doctors associated with this hospital, such as Shaker Dakhil, M.D., Jun Zhang, Chao H. Huang, and Anwaar Saeed.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Shaker Dakhil, M.D.Ascension Via Christi Hospitals Wichita6 years of reported clinical research
Expert in Breast Cancer
Expert in Lung Cancer
83 reported clinical trials
170 drugs studied
Jun ZhangHouston Methodist Hospital5 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
28 reported clinical trials
43 drugs studied
Chao H. HuangUniversity of Kansas Health System Saint Francis Campus6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
22 reported clinical trials
35 drugs studied
Anwaar SaeedUniversity of Kansas Cancer Center3 years of reported clinical research
Studies Colorectal Cancer
Studies Liver Cancer
20 reported clinical trials
37 drugs studied
Clinical Trials running at Lawrence Memorial Hospital
Lung Cancer
Bladder Cancer
Breast Cancer
Esophageal cancer
Bladder Carcinoma
Breast cancer
Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Kidney Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting2 awards Phase 34 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Lawrence Memorial Hospital?
Lawrence Memorial Hospital is a medical facility located in Lawrence, Kansas. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Lawrence Memorial Hospital is involved with conducting 395 clinical trials across 489 conditions. There are 23 research doctors associated with this hospital, such as Shaker Dakhil, M.D., Jun Zhang, Chao H. Huang, and Anwaar Saeed.
Where is Lawrence Memorial Hospital located?
**Lawrence Memorial Hospital**
- **Address:** 325 Maine Street, Lawrence, KS 66044
- **Location:** Approximately 2 miles from downtown Lawrence, near the intersection of Maine Street and 6th Street.
Who should I call to ask about financial aid or insurance network?
**Lawrence Memorial Hospital Financial Assistance**
- For financial assistance, including charity care, payment arrangements, and medical assistance programs, please contact our financial counselor at 785-505-5775.
- Application forms and further information are available through the financial counselor.
What insurance does Lawrence Memorial Hospital accept?
Lawrence Memorial Hospital accepts Blue Cross and Blue Shield of Kansas (BCBSKS) insurance plans. The hospital participates with most major managed care and governmental health insurance plans in the Northeast, including Medicaid and Medicare. Patients should contact their health insurance company directly to confirm specific plan and benefit coverage, as participation with health plans does not guarantee coverage.
What awards or recognition has Lawrence Memorial Hospital received?
**Lawrence Memorial Hospital, Lawrence, Kansas**
- Recognized as one of the 100 Top Hospitals by Truven Health Analytics.
- Received a $2 million grant from the Sunderland Foundation for support.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.